nach oben

Medical Oncology

Erschienen in:

01.12.2011 | Original paper

Pegfilgrastim overdose: case report and review of the literature

verfasst von: Orit Kaidar–Person, Mor Moskovitz, Tomer Charas, Wasim Alsharbati, Nissim Haim

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Single-dose pegfilgrastim is commonly used for the prophylaxis of neutropenia in patients receiving myelotoxic chemotherapy. We report a case of a 69-year-old man who was treated with chemotherapy for small-cell lung cancer and mistakenly self-administered a 36 mg overdose of pegfilgrastim, a sixfold increase over the scheduled dose.

Curran MP, Goa KL. Pegfilgrastim. Drugs. 2002;62:1207–13.PubMedCrossRef

Martinez C, et al. Efficacy and toxicity of high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors. Bone Marrow Transplant. 1999;24:1273–8.PubMedCrossRef

Pitini V, et al. Spontaneous rupture of spleen during peripheral stem-cell mobilization in a patient with breast cancer. Haematologica. 2000;85:559–60.PubMed

Becker PS, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant. 1997;3:45–9.PubMed

Donadieu J, Beaupain B, Rety-Jacob F, Nove-Josserand R. Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim. Haematologica. 2009;94:1175–7.PubMedCrossRef

Draper BK, Robbins JB, Stricklin GP. Bullous Sweet’s syndrome in congenital neutropenia: association with pegfilgrastim. J Am Acad Dermatol. 2005;52:901–5.PubMedCrossRef

Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (GCSF) in a patient with the adult respiratory distress syndrome. Chest. 1995;107:276–8.PubMedCrossRef

Dufour C, et al. Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease. Haematologica. 2010;95:684–5.PubMedCrossRef

Burstein HJ, et al. Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005;23:8340–7.PubMedCrossRef

10.

Ishiguro H, et al. Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim. Ann Oncol. 2008;19:1019–20.PubMedCrossRef

11.

Wolff AC, Jones RJ, Davidson NE, Jeter SC, Stearns V. Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support. J Clin Oncol. 2006;24:2392–4.PubMedCrossRef

Titel: Pegfilgrastim overdose: case report and review of the literature
verfasst von: Orit Kaidar–Person
Mor Moskovitz
Tomer Charas
Wasim Alsharbati
Nissim Haim
Publikationsdatum: 01.12.2011
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-010-9751-5

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Pegfilgrastim overdose: case report and review of the literature

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2011

Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research

Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells

Biochemical, pathological and oncological relevance of Gb3Cer receptor

CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma

RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie